| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1998;65:1400-1404
© 1998 The Society of Thoracic Surgeons
a Division of Pediatric Cardiology, Primary Children’s Medical Center, University of Utah, Salt Lake City, Utah, USA
Accepted for publication December 31, 1997.
Address reprint requests to Dr Day, Division of Pediatric Cardiology, Primary Children’s Medical Center, 100 North Medical Dr, Salt Lake City, UT 84113
e-mail: (ron.day{at}hsc.utah.edu)
Background. We have empirically used supplemental nitrogen in newborns with a functional single ventricle and ductal-dependent systemic perfusion to prevent pulmonary vasodilation and deliver a greater proportion of flow to the systemic circulation. Thus, we reviewed patient outcome to determine whether adverse pulmonary vascular effects may be associated with this therapy.
Methods. From December 1991 to December 1995, the fraction of inspired oxygen was adjusted, with supplemental nitrogen if necessary, to maintain an oxygen saturation near 75% in 20 newborns awaiting heart transplantation. Medical records were reviewed to evaluate (1) the duration of nitrogen therapy, (2) pulmonary vascular histology, (3) postoperative pulmonary hemodynamics, and (4) survival.
Results. Thirteen patients underwent heart transplantation, 4 patients died without surgical intervention, and 3 patients underwent late aortic reconstruction. Supplemental nitrogen was used without exceeding a fraction of inspired oxygen of 0.21 for 38 ± 6 days. One patient had evidence of changes of potentially irreversible pulmonary vascular disease. Pulmonary vascular resistance was not increased long-term in surviving patients.
Conclusions. Supplemental nitrogen can be used to maintain a systemic oxygen saturation near 75% for an extended period in newborns with ductal-dependent systemic perfusion with no long-term adverse effect on pulmonary vascular resistance.
This article has been cited by other articles:
|
|
 |
|
  M. R. Liske and J. L. Aschner Counterpoint: Hypoxia is not the Optimal Means of Reducing Pulmonary Blood Flow in the Preoperative Single Ventricle Heart J Appl Physiol, June 1, 2008; 104(6): 1836 - 1838. [Full Text] [PDF]
|
|
|
|
|
|
Rebuttal by Ebenroth J Appl Physiol, June 1, 2008; 104(6): 1838 - 1839. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Liske and J. L. Aschner Last Word on Point:Counterpoint: Hypoxia is/is not the optimal means of reducing pulmonary blood flow in the preoperative single ventricle heart J Appl Physiol, June 1, 2008; 104(6): 1843 - 1843. [Full Text] [PDF]
|
|
|
|
|
|
E. Ebenroth Point:Counterpoint: Hypoxia is/is not the optimal means of reducing pulmonary blood flow in the preoperative single ventricle heart J Appl Physiol, June 1, 2008; 104(6): 1835 - 1836. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Maeda, S. Yamaki, H. Kado, T. Asou, A. Murakami, and S. Takamoto Hypoplasia of the Small Pulmonary Arteries in Hypoplastic Left Heart Syndrome With Restrictive Atrial Septal Defect Circulation, September 14, 2004; 110(11_suppl_1): II-139 - II-146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stayer, J. Gouvion, L. Evey, and D. Andropoulos Subambient Gas Delivery Anesth. Analg., June 1, 2002; 94(6): 1674 - 1675. [Full Text] [PDF]
|
|
|
|
|
|
S. Tabbutt, C. Ramamoorthy, L. M. Montenegro, S. M. Durning, C. D. Kurth, J. M. Steven, R. I. Godinez, T. L. Spray, G. Wernovsky, and S. C. Nicolson Impact of Inspired Gas Mixtures on Preoperative Infants With Hypoplastic Left Heart Syndrome During Controlled Ventilation Circulation, September 18, 2001; 104 (2009): I-159 - I-164. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
